Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janusz Jankowski

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|September 15, 2009
Aspirin in the primary prevention of vascular diseaseJanusz Jankowski, Stephen Attwood, John deCaestecker, et al.
Scandinavian Journal of Gastroenterology|October 8, 2005
A family history of Barrett's oesophagus: another risk factor?Chris Groves, Janusz Jankowski, Fred Barker, et al.
BMJ (Clinical Research Ed.)|October 26, 2002
10-minute consultation: Gastro-oesophageal reflux diseaseJanusz Jankowski, Roger Jones, Brendan Delaney, et al.
World Journal of Surgery|July 25, 2003
Barrett's esophagus: environmental influences in the progression of dysplasiaRalph A Boulton, Bernhard Usselmann, Imtiyaz Mohammed, et al.
BMJ (Clinical Research Ed.)|October 12, 2002
GastroenterologyJanusz Jankowski, John de Caestecker, Bertus Eksteen, et al.
Scandinavian Journal of Gastroenterology|December 21, 2022
One bite or two? A comparison of single bite and double bite <u>bi</u>opsy <u>t</u>echniques in gastrointe<u>s</u>tinal endo<u>s</u>copy (BITES)Humayun Muhammad, Nicola Burch, Victoria Gordon, et al.
Lancet (London, England)|May 17, 2011
Aspirin in the prevention of cancerJanusz Jankowski, Hugh Barr, John deCaestecker, et al.
Cancer Research|March 18, 2004
An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagusJoseph C Harris, Philip A Clarke, Altaf Awan, et al.
The Lancet. Oncology|January 4, 2006
NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for biasJanusz Jankowski, John deCaestecker, Rebecca Harrison, et al.
The Lancet. Gastroenterology & Hepatology|October 11, 2025
Lessons learned from the BOSS trialOliver Old, Paul Moayyedi, Janusz Jankowski, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|September 15, 2009
Aspirin in the primary prevention of vascular diseaseJanusz Jankowski, Stephen Attwood, John deCaestecker, et al.
Scandinavian Journal of Gastroenterology|October 8, 2005
A family history of Barrett's oesophagus: another risk factor?Chris Groves, Janusz Jankowski, Fred Barker, et al.
BMJ (Clinical Research Ed.)|October 26, 2002
10-minute consultation: Gastro-oesophageal reflux diseaseJanusz Jankowski, Roger Jones, Brendan Delaney, et al.
World Journal of Surgery|July 25, 2003
Barrett's esophagus: environmental influences in the progression of dysplasiaRalph A Boulton, Bernhard Usselmann, Imtiyaz Mohammed, et al.
BMJ (Clinical Research Ed.)|October 12, 2002
GastroenterologyJanusz Jankowski, John de Caestecker, Bertus Eksteen, et al.
Scandinavian Journal of Gastroenterology|December 21, 2022
One bite or two? A comparison of single bite and double bite <u>bi</u>opsy <u>t</u>echniques in gastrointe<u>s</u>tinal endo<u>s</u>copy (BITES)Humayun Muhammad, Nicola Burch, Victoria Gordon, et al.
Lancet (London, England)|May 17, 2011
Aspirin in the prevention of cancerJanusz Jankowski, Hugh Barr, John deCaestecker, et al.
Cancer Research|March 18, 2004
An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagusJoseph C Harris, Philip A Clarke, Altaf Awan, et al.
The Lancet. Oncology|January 4, 2006
NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for biasJanusz Jankowski, John deCaestecker, Rebecca Harrison, et al.
The Lancet. Gastroenterology & Hepatology|October 11, 2025
Lessons learned from the BOSS trialOliver Old, Paul Moayyedi, Janusz Jankowski, et al.
Pageof 8